Selitrectinib
Selitrectinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).
| Trade Name | Selitrectinib |
| Generic | Selitrectinib |
| Selitrectinib Other Names | Selitrectinib |
| Type | |
| Formula | C20H21FN6O |
| Weight | Average: 380.427 Monoisotopic: 380.176087483 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Selitrectinib
